Skip to main content

Table 1 Demographics, Clinical and Outcome data of acute pancreatitis patient cohort

From: High-density lipoprotein cholesterol to low-density lipoprotein cholesterol ratio in early assessment of disease severity and outcome in patients with acute pancreatitis admitted to the ICU

ParametersAll (n = 166)Non-Survivor (n = 45)Survivor (n = 121)P
Demographic Data
 Age, mean (SD),y47.49 (15.06)49.67 (13.73)46.68 (15.53)0.310
 Male, n (%)97 (58.43)25 (55.60)72 (59.50)0.646
Etiology, n (%)   0.007
 Biliary71 (42.80)15 (33.30)56 (46.30) 
 Hyperlipidemia34 (20.50)5 (11.10)29 (24.00) 
 Others61 (36.70)25 (55.60)36 (29.80) 
Underlying medical conditions
 Hypertension, n (%)24 (14.50)5 (11.10)19 (15.70)0.455
 Diabetes Mellitus, n (%)28 (16.90)5 (11.10)23 (19.00)0.227
Severity, n (%)   0.533
 Moderately severe27 (16.30)6 (13.30)21 (17.40) 
 Severe139 (83.70)39 (86.70)100 (82.60) 
APACHEIIScorea, mean (SD)19.27 (7.32)22.53 (5.69)18.03 (7.50)< 0.001
Ranson’s Scorea, mean (SD)4.24 (1.55)4.29 (1.61)4.11 (1.36)0.493
CHOLa, mean (SD), mmol/L3.41 (2.79)3.00 (3.42)3.00 (3.42)0.257
HDL-Ca, mean (SD), mmol/L0.39 (0.28)0.26 (0.13)0.44 (0.31)< 0.001
LDL-Ca, mean (SD), mmol/L0.91 (0.70)0.54 (0.53)1.05 (0.71)< 0.001
H/L ratioa, mean (SD)0.72 (0.92)0.93 (1.29)0.64 (0.72)< 0.001
Statins usage**, n (%)2 (1.20)1 (2.22)1 (0.82)0.464
Ventilation free daysb, mean (SD), d16.87 (8.93)13.64 (9.16)18.07 (8.56)0.004
Renal replacement therapy, n (%)27 (16.30)12 (26.70)15 (12.40)0.149
Hospital cost, mean (SD), CHY182,392.76 (141,028)229,767 (163.568)164,627 (127,869)0.008
ICU LOS, mean (SD), d23.37 (22.40)20.91 (16.56)24.28 (24.22)0.391
Hospital LOS, mean (SD), d30.54 (23.30)23.27 (17.18)33.27 (24.73)0.014
  1. APACHE Acute Physiology and Chronic Health Evaluation, CHOL cholesterol, HDL-C High-density lipoprotein cholesterol, LDL-C Low-density lipoprotein cholesterol, H/L HDL-C/ LDL-C, LOS length of stay
  2. aon admission
  3. bwithin 28 days